Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models
Science Translational Medicine · 11.06.2025 · 17 (802)
DOI: 10.1126/scitranslmed.adq5331 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 11.06.2025. Verfasst von Shi Li und 18 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integr…. Hauptthemen laut MEDLINE: Gold, Glioma, Photochemotherapy, Metal Nanoparticles. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 82 Literaturangaben.
Abstract (Originalsprache)
The diffuse and infiltrative nature of high-grade gliomas poses ongoing challenges in treatment and management. Radiotherapy is an important glioma treatment, with a standard radiotherapy dose of 60 gray. However, high-dose radiotherapy is associated with radiation-induced side effects on normal tissue. Scintillator-mediated low-dose x-ray–induced photodynamic therapy using kilovoltage x-rays has been shown to be effective for multiple tumor types without causing damage to healthy tissue. However, x-ray–induced photodynamic therapy is yet to be explored in glioma because of the inability of the photosensitizers to cross the blood-brain barrier. Here, we present an integrated gold clustoluminogen containing protein-protected gold nanoclusters conjugated to a photosensitizer and a cell-penetrating peptide. Using intravital imaging, we showed that gold clustoluminogen crossed the intact blood-brain barrier in healthy animals and accumulated in tumors in two murine intracranial orthotopic glioma models. Gold clustoluminogen efficiently suppressed glioma growth and prolonged animal survival under ultralow-dose x-ray treatment (total 2 gray, megavoltage x-ray) using the same protocol as that used for clinical megavoltage radiotherapy. Moreover, gold clustoluminogen potently inhibited tumor growth in an orthotopic patient-derived xenograft glioma model with prolonged animal survival under ultralow-dose x-ray treatment. Gold clustoluminogen was eliminated through hepatic and renal excretion, with no observed toxicity. These results highlight new opportunities to develop clinically relevant glioma therapies with reduced side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, National Innovation Platform for Industry-Education Integration in Vaccine Research, School of Public Health, Xiamen University,…
- Department of Radiation Oncology, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen 361003, China.
- Department of Neurosurgery, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.
- Department of Neurosurgery, Xiamen Key Laboratory of Brain Center, Fujian Key Laboratory of Brain Tumors Diagnosis and Precision Treatment, First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen Univ…
ORCID-Profile: Shi Li, Shileng Chen, Yimin Li, Huaping Deng, Zongzhang Wang, Luchao Zhu, Jun Liu, Yiru Wang, Wenle Li, Qin Lin, Hongmin Chen
Zitieren
APA
Li, S., Chen, S., Li, Y., Sun, W., Li, J., Deng, H., Ding, H., Wang, Z., Zhu, L., Liu, J., Wang, M., Feng, Y., Xie, Y., Wang, Y., Liu, Y., Li, W., Lin, Q., Jiang, X., & Chen, H. (2025). Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models. Science Translational Medicine, 17(802). https://doi.org/10.1126/scitranslmed.adq5331
Vancouver
Li S, Chen S, Li Y, Sun W, Li J, Deng H, et al. Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models. Science Translational Medicine. 2025;17(802). doi:10.1126/scitranslmed.adq5331
BibTeX
@article{Li2025,
author = {Li, Shi and Chen, Shileng and Li, Yimin and Sun, Wenjing and Li, Junjun and Deng, Huaping and Ding, Haizhen and Wang, Zongzhang and Zhu, Luchao and Liu, Jun and Wang, Minjie and Feng, Yushuo and Xie, Yuanyuan and Wang, Yiru and Liu, Yaqing and Li, Wenle and Lin, Qin and Jiang, Xiaobing and Chen, Hongmin},
title = {Targeted suppression of glioma by ultralow-dose x-ray–induced photodynamic therapy and gold-based nanoclusters in preclinical models},
journal = {Science Translational Medicine},
year = {2025},
volume = {17},
number = {802},
doi = {10.1126/scitranslmed.adq5331}
}
EUVIMED